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Roles of G-Protein bg, Arachidonic Acid, and Phosphorylation in
Convergent Activation of an S-Like Potassium Conductance by
Dopamine, Ala-Pro-Gly-Trp-NH2, and Phe-Met-Arg-Phe-NH2
Hind van Tol-Steye,1,2 Johannes C. Lodder,1 Huibert D. Mansvelder,1 Rudi J. Planta,2
Harm van Heerikhuizen,2 and Karel S. Kits1
Departments of 1Neurophysiology, Research Institute Neurosciences, and 2Biochemistry and Molecular Biology, Faculty
of Chemistry, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands
Dopamine and the neuropeptides Ala-Pro-Gly-Trp-NH2 (APG-
Wamide or APGWa) and Phe-Met-Arg-Phe-NH2 (FMRFamide
or FMRFa) all activate an S-like potassium channel in the light
green cells of the mollusc Lymnaea stagnalis, neuroendocrine
cells that release insulin-related peptides. We studied the sig-
naling pathways underlying the responses, the role of the
G-protein bg subunit, and the interference by phosphorylation
pathways. All responses are blocked by an inhibitor of arachi-
donic acid (AA) release, 4-bromophenacylbromide, and by
inhibitors of lipoxygenases (nordihydroguaiaretic acid and
AA-861) but not by indomethacin, a cyclooxygenase inhibi-
tor. AA and phospholipase A2 (PLA2 ) induced currents with
similar I–V characteristics and potassium selectivity as do-
pamine, APGWa, and FMRFa. PLA2 occluded the response
to FMRFa. We conclude that convergence of the actions of
dopamine, APGWa, and FMRFa onto the S-like channel
occurs at or upstream of the level of AA and that formation of
lipoxygenase metabolites of AA is necessary to activate the
channel. Injection of a synthetic peptide, which interferes
with G-protein bg subunits, inhibited the agonist-induced
potassium current. This suggests that bg subunits mediate
the response, possibly by directly coupling to a phospho-
lipase. Finally, the responses to dopamine, APGWa, and
FMRFa were inhibited by activation of PKA and PKC, sug-
gesting that the responses are counteracted by PKA- and
PKC-dependent phosphorylation. The PLA2-activated po-
tassium current was inhibited by 8-chlorophenylthio-cAMP
but not by 12-O-tetradecanoylphorbol 13-acetate (TPA).
However, TPA did inhibit the potassium current induced by
irreversible activation of the G-protein using GTP-g-S. Thus,
it appears that PKA targets a site downstream of AA forma-
tion, e.g., the potassium channel, whereas PKC acts at the
active G-protein or the phospholipase.
Key words: FMRFamide; dopamine; neuropeptide; K1-cur-
rent; S-current; molluscs; arachidonic acid; G-protein bg sub-
units; neuron; signal transduction; convergence
G-protein-mediated activation of K1 channels involves either
direct interaction of G-proteins with the channels [so-called
G-protein-gated inward rectifier K1 channels (GIRKs); Wick-
man and Clapham, 1995] or intervention of an enzyme system
and second messengers. The latter route has been well docu-
mented in molluscan systems. Thus, Phe-Met-Arg-Phe-NH2
(FMRFamide or FMRFa)-induced activation of S-channels in
sensory cells of Aplysia (Piomelli et al., 1987a; Belardetti et al.,
1989; Buttner et al., 1989), an S-like current in neuron B5 of
Helisoma (Bahls et al., 1992) and an S-like but voltage-dependent
K1-current in the caudodorsal cells of Lymnaea (Kits et al.,
1997), involves lipoxygenase metabolites of arachidonic acid
(AA). However, other studies suggested AA-independent activa-
tion of K1 channels. Examples are the S-current activated by the
peptide myomodulin in Aplysia (Critz et al., 1991) and a K1-
conductance activated by dopamine, glutamate, and a muscarinic
agonist in Planorbarius (Bolshakov et al., 1993).
Previously, we described the convergent activation of an S-like
K1 channel by the classical transmitter dopamine and the neu-
ropeptides Ala-Pro-Gly-Trp-NH2 (APGWamide or APGWa)
and FMRFa in the light green cells (LGCs) of Lymnaea stagnalis
(van Tol-Steye et al., 1997), a set of growth-regulating neurons
that produce insulin-related peptides (Geraerts, 1976; Geraerts et
al., 1991; Smit et al., 1988). The responses are G-protein-
dependent, but the signaling pathway has not been elucidated.
Here, we focus on three main questions. (1) What is the signal
transduction pathway underlying the convergent activation of the
K1 channel by dopamine and APGWa and FMRFa? Conver-
gence may occur at any site between the receptors and the
channel, implying that the agonists may use completely different
or identical pathways. To solve this, we used pharmacological
tools to interfere with signal transduction. (2) Which G-protein
subunit, a or bg, is the active mediator in these responses? Unlike
for GIRKs in which Gbg subunits induce the response (Clapham
and Neer, 1997; Isomoto et al., 1997), for receptor-operated K1
channels in molluscs (Sasaki and Sato, 1987; Volterra and
Siegelbaum, 1988; Bolshakov et al., 1993), it is unclear whether
Ga or bg subunits are the active mediators. To address this
problem, we used a peptide that specifically interacts with bg-
mediated signaling (Koch et al., 1993; Macrez et al., 1997). (3) Do
modulatory pathways interact with the K1 current response? In
LGCs, responses to dopamine are inhibited by cAMP. This
resembles the situation in S channels in which protein kinase A
(PKA)-dependent phosphorylation shuts down the channels
(Shuster et al., 1985). Therefore, we studied for all three messen-
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gers the role of phosphorylation by PKA and protein kinase C
(PKC) in modulation of the current responses. Also, we asked
which sites in the signaling route are targeted by PKA and PKC
by studying the effect of PKA and PKC activation on responses
activated downstream of the receptors.
We provide evidence that channel activation by all three ago-
nists involves lipoxygenase metabolism of AA, implying that not
only FMRFa but also dopamine and APGWa, couple to the AA
pathway. Gbg subunits appear to mediate the response and pre-
sumably activate the phospholipase catalyzing AA formation.
The AA pathway is modulated by phosphorylation through PKA
and PKC, with each kinase apparently targeting a separate site in
the signaling route.
MATERIALS AND METHODS
Animals and cells. Adult pond snails (Lymnaea stagnalis), bred in the
laboratory under standard conditions (van der Steen et al., 1969), were
used. LGCs were dissociated mechanically from the CNS after 45 min
incubation at 37°C in HEPES-buffered saline (HBS) (see below) supple-
mented with 0.2% trypsin (type III; Sigma, St. Louis, MO). Dissociated
cells were plated in culture dishes (Costar, Cambridge, MA) containing
HBS and were left undisturbed for at least 1 hr to allow the cells to attach
to the bottom of the dish. In all experiments, isolated cells (diameter of
;60 mm) without neurites were used. Cells were always used within 7 hr
after isolation.
Solutions and chemicals. CNSs and isolated cells were bathed in HBS
containing (in mM): NaCl 30, NaCH3SO4 10, NaHCO3 5, KCl 1.7, CaCl2
4, MgCl2 1.5, and HEPES 10, pH 7.8 adjusted with NaOH. The same
buffer was used as extracellular solution during electrophysiological
recordings, unless otherwise specified. Extracellular high-K 1 solution
contained 20 mM KCl and 10 mM NaCl. For the remainder, it was
identical to HBS. Internal pipette solution contained (in mM): KCl 29,
ATPMg 2, GTP (Tris-salt) 0.1, HEPES 10, EGTA 11, and CaCl2 2.3, pH
7.4 adjusted with KOH.
Solutions of agonists and all other drugs were freshly prepared before
use by dilution from stock solutions into extracellular or intracellular
medium. The following agents were prepared as stocks in DMSO:
4-bromophenacylbromide (4-BPB), nordihydroguaiaretic acid (NDGA),
indomethacin, and 8-chlorophenylthio-cAMP (8-cpt-cAMP) (all ob-
tained from Sigma); 12-O-tetradecanoylphorbol 13-acetate [(TPA) also
referred to as phorbol 12-myristate 13-acetate (PMA)], 4-a-phorbol
12-myristate 13-acetate (4a-PMA), staurosporin, and okadaic acid (all
obtained from Research Biochemicals, Natick, MA); AA (Sigma and
Research Biochemicals); and 1-(2-nitrophenyl)ethyl cAMP (NPE-caged
cAMP) (Molecular Probes, Eugene, OR). AA-861 stock solutions (Bi-
omol, Plymouth Meeting, PA) were prepared in ethanol. Stocks of
3,4-dihydroxyphenylethylamine hydrochloride (dopamine) (Sigma),
APGWamide (American Peptide Co., Sunnyvale, CA), FMRFamide
(Peninsula Laboratories Inc., Belmont, CA), phospholipase A2 (PLA2 )
from bee venom (Sigma), and bg-interacting peptide (peptide G) (Isogen
Bioscience BV, Maarssen, The Netherlands) were prepared in distilled
water. Stocks of cAMP (Boehringer Mannheim, Mannheim, Germany)
were prepared in distilled water containing 2 mM KOH. cAMP-
dependent protein kinase inhibitor 5–24 amide (wiptide) (Peninsula
Laboratories Inc.) was directly dissolved in pipette medium. Peptide G is
an N-acylated and C-amidated 28-mer: WKKELRDAY-
REAQQLVQRVPKMKNKPRS, corresponding to amino acids 643–
670 from the bg-binding sequence of b-adrenergic receptor kinase 1
(bARK1) (Koch et al., 1993). AA-containing solutions were always
prepared under N2 and sonicated before use. Dopamine, APGWa, FM-
RFa, 8-cpt-cAMP, staurosporin, AA, and PLA2 were applied to the cell
by means of a gravity-driven Y-tube system described previously (Kits et
al., 1997) or by means of a Picospritzer (General Valve, Fairfield, NJ).
The vital dye amaranth (0.01%) (Merck, Darmstadt, Germany) was
added to visualize the application. Because of the continuous perfusion
of the culture dish with extracellular solution, applied agents were
washed away within seconds after application was stopped. Okadaic acid
and NPE-caged cAMP were applied intracellularly via the patch elec-
trode. Peptide G was administered by microinjection. All other solutions
were administered via the pump-driven bath perfusion system, unless
stated otherwise. Bath medium was completely replaced within 5 min.
Transmitters were dissolved in the same solution as used for perfusion.
Recordings were always started in standard extracellular solution. When
high potassium or drugs were bath-perfused during an experiment,
subsequent experiments were performed on a fresh dish of cells.
Electrophysiolog ical recordings and microinjections. Whole-cell voltage-
clamp recordings were made with an Axoclamp-2B or Axopatch-200B
amplifier (Axon Instruments, Foster City, CA). Voltage-clamp electrodes
(2–4 MV) were pulled from Clark GC-150T or GC-150 glass (Clark
Electromedical Instruments, Reading, UK). Seal resistance was $1 GV;
after disruption of the patch membrane, series resistance (,5 MV) was
compensated for $70%. Sharp injection electrodes were pulled from
Clark GC-150F glass; resistance was 15–20 MV when filled with standard
pipette medium. After impalement of the cell, which was confirmed by
monitoring the membrane potential using a custom-built microelectrode
amplifier, injection (#1% of the cell volume) was accomplished under
visual control, using a Picospritzer.
Data-acquisition was controlled by a CED 1401 (Cambridge Electron-
ics Design, Cambridge, UK) or a Digidata 1200 (Axon Instruments)
analog-to-digital converter connected to a personal computer. Voltage-
clamp software developed in our laboratory, as well as pClamp (Axon
Instruments), was used. Current recordings were filtered at 100 Hz,
sampled at .200 Hz, and stored on disk. This system allowed simulta-
neous control of applied voltage protocols, data acquisition, and drug
application.
Cells were kept at a holding potential of 280 mV. Before application
of agonist, a voltage step to 240 mV was made, unless stated otherwise,
to enhance the driving force for potassium. I–V relationships were
determined using ramp protocols, imposing linear voltage ramps (slope
of 34 mV/sec; duration of 5 sec). Current responses to ramps under
control conditions (no agonist present) were subtracted from those
measured after application (10–40 sec) of agonist to obtain the current–
voltage relationship of the agonist-induced current.
Error bars indicate SEM.
Flash experiments. Uncaging of NPE-caged cAMP was accomplished
using a 35 S mercury arch Flashtube and Strobex model 238 power pack
(Chadwick-Helmuth, El Monte, CA), delivering 200 J per flash. For
these experiments, the bottoms of the Costar culture dishes, normally
used to plate the cells, were replaced by glass coverslips, and an Axiovert




Previously, we have shown that the transmitter dopamine and the
neuropeptides APGWa and FMRFa activate a single type of
potassium channel in the neuroendocrine LGCs of the pond snail
Lymnaea stagnalis (van Tol-Steye et al., 1997). To assess whether
AA is involved in activation of this potassium channel, we tested
the effect of 4-BPB. 4-BPB irreversibly blocks the formation of
AA by inhibiting phospholipase A2 activity or by inhibiting the
combined action of phospholipase C (PLC) and diacylglycerol
lipase (Blackwell and Flower, 1983; Piomelli et al., 1987a). The
current responses to all three transmitters were blocked for $90%
by 10 mM 4-BPB (Fig. 1). The inhibition was obtained within
10–20 min.
Whereas 4-BPB inhibited the responses, AA (5–50 mM) mim-
icked the agonist-induced effects on the LGCs (Figs. 2A, 3).
However, the AA-evoked responses were rather variable in in-
tensity and stability after repeated applications (2–20 sec appli-
cations, once per minute). In some cases, AA application failed to
induce a response. Although we prepared all AA-containing
solutions under N2 and sonicated solutions before use, these
problems could well be attributable to the fact that AA is poorly
soluble in aqueous solutions, tends to stick to glassware and
tubing (Yamada et al., 1994), and is prone to oxidation. In line
with this explanation, we found that a given solution was either
effective or ineffective in all cells tested. To consolidate our
observation that AA is capable of mimicking the effect of dopa-
mine, APGWa, and FMRFa on the LGCs, we stimulated AA
formation in the cell by application of PLA2. Extracellular appli-
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cation of PLA2 (50–122.5 U/ml, corresponding to micromolar
range) consistently induced a slow outward current similar to that
evoked by the three agonists (Figs. 2A, 3). Figure 2A shows
examples of the AA- and PLA2-induced responses and the
dopamine-induced potassium current.
If direct application of AA or PLA2 activates the same chan-
nels as the agonists, there should be occlusion of the agonist
responses and the PLA2-evoked response. To test this, we used a
saturating dose of FMRFa (10 mM) to evoke the agonist-induced
response because it was shown previously that FMRFa maximally
activates the population of K1 channels involved and completely
occludes the responses to the other agonists (van Tol-Steye et al.,
1997). This response was compared with the response to com-
bined application of PLA2 (50 U/ml) and FMRFa (n 5 4). Figure
2B shows there is no summation of the responses, i.e., that
FMRFa completely occludes the response to PLA2. If FMRFa
was applied during the PLA2 current response, an increase in
current amplitude was observed up to the level of the response to
FMRFa alone (n 5 4) (Fig. 2C). This indicates that PLA2
activates the same population of channels as FMRFa but does so
less effectively.
As a next test to establish that PLA2 and AA evoke the same
current as dopamine, APGWa, and FMRFa, we determined the
reversal potential and voltage dependence of the responses using
voltage ramp protocols (Fig. 3). In standard extracellular potas-
sium, the current induced by dopamine reversed at 282.0 6 0.4
mV (6 SEM; n 5 4) and that induced by AA and PLA2 at
281.9 6 2.3 mV (n 5 3) and 283.6 6 0.4 mV (n 5 7), respec-
tively. At high extracellular potassium, the reversal potential
shifted to 223.1 6 0.1 mV for dopamine (n 5 4), 223.1 6 1.3 mV
for AA (n 5 2), and 221.2 6 1.1 mV for PLA2 (n 5 2). Thus, for
the three agents, the shift in reversal potential caused by the
change in extracellular potassium concentration amounts to ;60
mV. This corresponds well with the value calculated by the
Nernst equation for potassium (61.6 mV), indicating that the
current induced by AA and PLA2, like that induced by dopa-
mine, APGWa, and FMRFa, is carried by potassium.
The I–V relationship of the K1 channels activated by dopa-
mine, FMRFa, and APGWa has a characteristic shape that is a
result of outward rectification, accounted for by asymmetry in
potassium concentrations across the membrane and a slight volt-
age dependence (van Tol-Steye et al., 1997). The I–V relation-
ships of the AA- and PLA2-induced currents also display these
properties (Fig. 3A). Outward rectification is especially evident at
standard extracellular potassium. Voltage dependence is appar-
ent at voltages below approximately 2100 mV, where all conduc-
tances decreased despite the increasing driving force. This is best
appreciated at 20 mM [K1]o. To permit a better comparison,
normalized I–V curves are shown Figure 3B. In low [K1]o , the
I–V curves of the dopamine-, AA-, and PLA2-induced responses
overlap completely at all voltages negative to approximately 220
mV. Also in high [K1]o , the overall shape of the I–V relationships
is very similar. The differences between the dopamine- and
PLA2-evoked currents at voltages positive to 220 mV reflect
effects of the agonist on high voltage-gated calcium channels that
are not mediated by activation of PLA2 (H. van Tol-Steye and K.
Kits, unpublished observations). The much stronger deviation of
the AA-induced current at positive potentials is unexplained.
The data presented suggest that AA, whether applied exog-
enously or formed endogenously by application of PLA2, acti-
vates the same type of potassium channel as dopamine, APGWa,
and FMRFa. Together with the fact that an inhibitor of AA
Figure 1. 4-BPB inhibits the outward current induced by dopamine,
APGWa, and FMRFa. For each agonist, the control response and the
strongly reduced response in the presence of 4-BPB are shown. Responses
were evoked by 2 sec applications of agonist by means of Y-tube. Graphs
are plots of current amplitudes ( I ), normalized to the current response at
t 5 0 (I0), against time. Arrows indicate the start of bath perfusion with
0.01% DMSO in standard medium (control, open diamonds; n 5 3 for
each agonist) or with 10 mM 4-BPB ( filled diamonds; n 5 3 for each
agonist; n indicates number of cells tested per agonist). SEMs are indi-
cated only by upward error bars. Concentrations used were as follows:
dopamine, 1 mM; APGWa, 7 mM; and FMRFa, 0.1 mM.
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formation potently inhibits the responses to the three transmit-
ters, this strongly suggests that formation of AA underlies the
generation of these responses.
To test whether AA itself, or one of its metabolites, is respon-
sible for the generation of the potassium current, we tested
several inhibitors of AA metabolism. NDGA, an inhibitor of the
lipoxygenase pathway (Needleman et al., 1986; Yamada et al.,
1994), is active in Aplysia nervous tissue, with an IC50 of 3 mM
(Piomelli et al., 1987a,b). In the LGCs, 15 mM NDGA inhibited
the responses evoked by dopamine, APGWa, and FMRFa for
;90% or more (n 5 3 in all cases) (Fig. 4A) within 20–30 min. A
similar amount of inhibition was observed with 5 mM NDGA
within 40–60 min in a first set of experiments with FMRFa (data
not shown).
Indomethacin is an inhibitor of the cyclooxygenase pathway. In
Aplysia ganglia, indomethacin inhibits the formation of prostag-
landines, with an IC50 of 0.5 mM. The lipoxygenase pathway is
only affected at higher concentrations (IC50 of .10 mM) (Piomelli
et al., 1987a). Perfusion of the LGCs during ;25 min with 5 mM
indomethacin did not affect the current responses to dopamine,
APGWa, and FMRFa compared with the control situation in
which the cells were perfused with standard medium containing
0.01% DMSO (Fig. 4A). At this concentration, DMSO did not
affect the responses. As a final additional test of the involvement
of the lipoxygenase pathway, we used the lipoxygenase blocker
AA-861 (Yamada et al., 1994) on dopamine and APGWa re-
sponses, both of which were significantly reduced (dopamine,
64.8 6 4.1% block with 4 mM AA-861; n 5 3; APGWa, 61.6 6 2.1
and 84.1 6 0.1% block with 4 and 10 mM AA-861, respectively;
n 5 3 for both concentrations; unpaired t test; p # 0.01, tested
against 0.05% ethanol controls; n 5 3).
To demonstrate that the exogenous bee venom-derived PLA2
that we used specifically forms AA and starts the same cascade as
the agonists, we tested whether NDGA blocks the PLA2-induced
response. Figure 4B shows that NDGA (15 mM) blocks the
response to PLA2 (50 U/ml) by 80 6 4% (n 5 11). In three of
Figure 2. PLA2 and AA are involved in the signaling route activated by the agonists. A, AA and PLA2 induce an outward current, similar to that
induced by dopamine. Bars indicate extracellular applications of AA (5 sec, 50 mM), PLA2 (20 sec, 122.5 U/ml), and dopamine (1 sec, 1 mM). The cells
were voltage clamped at 240 mV. Responses are from different cells. B, C, FMRFa occludes the response to PLA2. B, Combined application of FMRFa
and PLA2 fails to show summation of the responses to FMRFa and PLA2. Average amplitudes (right) of the responses to a maximal dose of FMRFa (10
mM) alone and to the subsequently applied combination of FMRFa and PLA2 (50 U/ml) (n 5 4). C, Application of FMRFa during a response to PLA2
increases the current amplitude up to the level of the response to FMRFa alone. The right panel shows the average current amplitudes to FMRFa alone
and to PLA2 alone compared with the response amplitude obtained when FMRFa was applied during a PLA2 response (n 5 4).
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Figure 3. AA and PLA2 induce a current with similar I–V characteristics as the current induced by dopamine, both in standard and high extracellular
[K 1]o. A, I–V relationships of the current induced by AA (50 mM), PLA2 (50–122.5 U/ml), or dopamine (1 mM) were determined with the use of linear
voltage ramp protocols (34 mV/sec) as described in Materials and Methods. Left panels, Standard extracellular potassium (1.7 mM; n 5 3, n 5 4, n 5 7 for
AA, PLA2 , and dopamine, respectively). Right panels, High extracellular potassium (20 mM; n 5 2, n 5 4, n 5 2 for AA, PLA2 , and dopamine, respectively).
B, Curves from A were normalized with respect to the current at 240 mV (1.7 mM K 1) or to the peak inward current amplitude (20 mM K 1).
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these experiments, responses to PLA2 were evoked repeatedly
before NDGA was applied, which confirmed that control re-
sponses to PLA2 were stable.
We conclude from these data that (1) AA metabolites of the
lipoxygenase pathway, formed after activation of the receptors for
dopamine, APGWa, and FMRFa, are responsible for generation
of the potassium current, and (2) convergence onto the potassium
channel occurs at an early step in the signal transduction path, i.e.,
at or even upstream of the level of AA.
Involvement of G-protein bg subunits
We next asked which G-protein subunit mediates the responses.
In several cases, bg subunits of heterotrimeric G-proteins have
been implicated in the activation of PLA2 (Jelsema and Axelrod,
1987; Murayama et al., 1990). Because the responses to dopa-
mine, APGWa, and FMRFa are all G-protein-dependent (van
Tol-Steye et al., 1997) and mediated by AA, as demonstrated
above, our strategy was to confine the action of the bg subunits.
To this end, we investigated the effect of a synthetic peptide,
peptide G, which was demonstrated previously to interfere with
bg-mediated signaling (Koch et al., 1993; Macrez et al., 1997).
Peptide G consists of 28 amino acids and is derived from the
bg-binding sequence of bARK1 (Koch et al., 1993). After three
control dopamine applications, peptide G was injected into the
cell (final concentration estimated to be #50 mM), after which
dopamine was applied again. Injection of peptide G caused an
irreversible reduction of the dopamine response by 79 6 4% (n 5
5), whereas control injections with carrier had hardly any effect
(8 6 1% reduction of the dopamine response; n 5 3) (Fig. 5A).
The bg-interacting peptide in principle might, apart from com-
peting with effector molecules for binding free bg, also compete
with Ga for binding to bg and thus reduce the amount of
functional heterotrimeric G-protein available for activation by
receptors (but see Koch et al., 1994; Macrez et al., 1997). To rule
out this option, we induced sustained and irreversible activation
of the G-protein by repeated applications (approximately six) of
agonist, either dopamine or FMRFa, with the nonhydrolyzable
GTP-analog GTP-g-S (200 mM) in the pipette medium (Fig. 5B).
This procedure results in the development of a sustained outward
current that only decays over a period of several minutes after
washout of the agonist (cf. van Tol-Steye et al., 1997). Figure 5, C1
and C2, illustrates the effect of peptide G on this sustained
current. Injection of the peptide caused a rapid reduction of the
current (.50% within 1 min). Injection of carrier solution, how-
ever, hardly affected the sustained current (Fig. 5C3). The results
obtained for dopamine and FMRFa were highly similar (both n 5
4). Thus, also when the G-protein is irreversibly activated, the
peptide has an inhibitory effect on the potassium current re-
4
itor of AA-release 4-BPB (10 mM), the lipoxygenase inhibitor NDGA (15
mM), and the cyclooxygenase inhibitor indomethacin (Indom; 5 mM).
Asterisks indicate significant difference with respect to the DMSO control
(unpaired t test; p , 0.01). Apart from controls in which n 5 6, experi-
mental groups were n 5 3 for each agonist. B, NDGA also blocks the
current induced by bee venom-derived PLA2 , indicating that exogenous
PLA2 acts specifically to produce AA. Shown are the average response
amplitudes to applications of PLA2 (50 U/ml) in the absence and presence
of 15 mM NDGA (n 5 11). NDGA was applied for 10 min before PLA2
was tested. Inset, Superimposed traces showing a control response to
PLA2 and the strong reduction of this response by NDGA (responses
from the same cell). *p , 0.01; paired t test.
Figure 4. Inhibitors of phospholipase and lipoxygenase reduce the re-
sponses to dopamine, APGWa, and FMRFa. A, Percentage reduction of
the potassium current elicited by dopamine, APGWa, and FMRFa (top,
middle, and bottom, respectively) after perfusion of the cells with standard
medium (control ), 0.01% DMSO-containing medium (DMSO), the inhib-
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sponse. This suggests that this inhibitory effect is a result of
interference with bg-induced activation of effector (PLA2) and
not of reduction of the amount of functional heterotrimeric
G-protein.
Effects of cAMP on agonist-induced responses
Previous work in our laboratory demonstrated that the dopamine-
induced hyperpolarization of the LGCs is inhibited by the
cAMP-analog 8-cpt-cAMP and by forskolin (which activates ad-
enylyl cyclase) and IBMX (an inhibitor of phosphodiesterase)
(De Vlieger et al., 1986). To test whether the outward current
responses induced by dopamine, APGWa, and FMRFa are all
inhibited by cAMP, we used caged cAMP. NPE-caged cAMP
(209 mM) was included in the pipette medium and allowed to
diffuse into the cell after establishing the whole-cell configura-
tion. Caged cAMP was photolyzed by a flash of UV light (360
nm), as was confirmed in similar experiments on voltage-gated
calcium currents known to be increased by cAMP-analogs in
other cells of Lymnaea (Dreijer and Kits, 1995). When a flash was
given just before application of agonist (at a membrane potential
of 240 mV), the potassium current evoked by the agonist was
greatly reduced [83.8 6 1.4% (n 5 2), 87.5 6 1.9% (n 5 2), and
66.5 6 4.0% (n 5 5) for dopamine, APGWa, and FMRFa,
respectively] (Figure 6A). The flash itself had virtually no effect
(data not shown). If the flash was given when the agonist-induced
current was at its maximum, the outward current declined rapidly
(within 5 sec), as shown in Figure 6B (dopamine, n 5 3; APGWa,
n 5 2; FMRFa, n 5 6). Thus, cAMP not only prevents the
response but also inhibits an ongoing response. In the continuous
presence of agonist, the current recovered within 30–50 sec to the
level before the flash. Probably the recovery reflects phosphodi-
esterase activity in the cell rather than desensitization of the
cAMP effect because the current was reinhibited after a second
flash (n 5 8) (Fig. 6C, APGWa). The experiments presented here
indicate that the responses induced by dopamine, APGWa, and
FMRFa in the LGCs are all inhibited by cAMP. This conclusion
was further substantiated in experiments using either extracellu-
larly applied 8-cpt-cAMP, a membrane-permeable nonhydrolyz-
able cAMP-analog, or intracellularly applied cAMP (Fig. 6D,
dopamine; other data not shown).
To study whether cAMP acts by stimulation of PKA, we tested
the effect of 8-cpt-cAMP on the dopamine response in the pres-
ence of the PKA inhibitor wiptide. Figure 6D shows that, when
wiptide (100 mM) was included in the electrode, the inhibitory
effect of 8-cpt-cAMP (1 mM) on the dopamine response was
significantly smaller than in the absence of wiptide (31 6 5% vs
89 6 2%; n 5 3 for both treatments; unpaired t test; p , 0.005).
Wiptide had no effect on the dopamine response. We conclude
that the inhibition of the agonist-induced potassium current
Figure 5. bg-interacting peptide (peptide G) inhibits the potassium current response. A, Reduction of the response to dopamine after injection of
peptide G (79 6 4%; n 5 5) or injection of carrier (8 6 1%; n 5 3). *p , 0.001; unpaired t test. B, Induction of the sustained K 1 current as a result
of irreversible activation of the G-protein. Repeated application of agonist with 200 mM GTP-g-S in the pipette induces a sustained current (b), which
is the irreversible part of the response. In the right panel, it is also seen as the increased holding current before the response. Shown are the first and
last response to the agonist, in this example FMRFa; arrows indicate application of agonist during the step to 240 mV. The sustained current is only
detected at 240 mV, when the driving force for potassium is large. Notice that the holding current at 280 mV ( a) remains constant. C1, Effect of peptide
G on the sustained potassium current, induced as in B, using dopamine as agonist. Sustained current amplitude was measured once every 2 min. Injection
of peptide G (indicated by arrow) is done after the last dopamine application. (Concentration of peptide G in injection electrode was 5 mM, and final
concentration is estimated to be #50 mM.) C2, Example trace of the immediate effect of peptide G on the sustained current at 240 mV. Arrow marks
injection of peptide G. C3, Like B2 but with injection of carrier instead of peptide G. Obviously, the carrier has no effect.
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by cAMP and analogs is mediated by PKA-dependent
phosphorylation.
Effects of phorbol ester on agonist-induced responses
To investigate whether PKC modulates the responses to the three
agonists under study also, we tested the effects of TPA, a phorbol
ester activator of PKC. Bath perfusion of TPA (50 nM) caused a
significant reduction of the current induced by all three agonists
(Fig. 7A). After ;16 min, the currents induced by dopamine,
APGWa, and FMRFa were reduced by 71.3 6 4.0% (n 5 5),
65.9 6 5.7% (n 5 3), and 88.5 6 1.3% (n 5 3), respectively. The
PKC inhibitor staurosporin (1 mM) significantly reduced the inhi-
bition by TPA of the response to FMRFa to 16.2 6 3.1 (unpaired
t test; p , 0.001; n 5 3) (Fig. 7B). Staurosporin did not affect the
response to FMRFa. These data suggest that the responses
induced by dopamine, APGWa, and FMRFa are all inhibited
by PKC.
Effects of phosphatase inhibitor
Because the K1 current responses are inhibited by PKA- and
PKC-dependent phosphorylation, it is to be expected that inhi-
bition of phosphatase activity will have similar effects. To test
this, we studied the effect of the phosphatase inhibitor okadaic
acid (Cohen et al., 1990) on the dopamine-induced response.
When okadaic acid was included in the patch electrode (1–2 mM),
the dopamine-induced response decreased within ;30 min to
48.2 6 6.7% of the initial value, measured directly after rupture
of the seal (n 5 5; data not shown). Controls with 1% DMSO in
the patch electrode did not show a decrease of the dopamine-
induced current within the same period of time (n 5 2; data not
shown).
The results with cAMP, TPA, and okadaic acid suggest that
phosphorylation of the channel or a component in the AA path-
Figure 6. cAMP-dependent phosphorylation inhibits the responses to dopamine, APGWa, and FMRFa. A1, Peak current amplitudes as a function of
pulse number. a–c denote traces depicted in corresponding panels in A. A2, Superimposed K 1 current responses to dopamine, APGWa, or FMRFa as
indicated, before (a) and directly after (b) flash-photolysis of NPE-caged cAMP and after $60 sec recovery (c). Arrows indicate timing of the flashes
2–3 sec before agonist application. NPE-caged cAMP was added to the pipette solution at 209 mM. All responses were evoked at a potential of 240 mV.
Uncaged cAMP strongly reduces the responses, although it has no effect on the holding current at 240 mV. B, Superimposed traces of a response
interrupted by flash-photolysis of caged cAMP at the peak of the potassium current and the response after $60 sec recovery. Inhibition of current
responses by cAMP is fast and reversible. Shown is an example with dopamine. C, Effect of repeated flashes on the current response in the continuous
presence of agonist. After the first decrease attributable to uncaging of cAMP, the response recovers to a level similar to that before the flash, whereas
a second flash induces a similar inhibition of the response. Shown is an example with APGWa. D, Percentage reduction of the dopamine response after
3 min perfusion with 1 mM 8-cpt-cAMP, with and without the PKA inhibitor wiptide (100 mM) in the pipette medium. The inhibitory effect of
8-cpt-cAMP is strongly reduced by wiptide. n 5 3 for both groups. *p , 0.005; unpaired t test.
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way inhibits the responses, or alternatively, that the AA pathway
involves a dephosphorylation step.
The AA pathway and the
phosphorylation–dephosphorylation cycle
To test at what site PKA and PKC interact with the signaling
cascades activated by dopamine, APGWa, and FMRFa, we ex-
amined the effect of PKA and PKC stimulation on the signal
transduction pathway downstream of AA formation. Thus, the
potassium current response to application of exogenous PLA2 (50
U/ml) was measured before and after 10 min perfusion of 8-cpt-
cAMP (100 mM; n 5 6), TPA (50 nM; n 5 3), the inactive phorbol
ester 4a-PMA (50 nM; n 5 3), and DMSO-containing medium
(0.05%; n 5 4) (Fig. 8). After perfusion with 8-cpt-cAMP, the
response to PLA2 was reduced by 88 6 5%, which was signifi-
cantly different (unpaired t test; p , 0.01) from the effect of
perfusion with DMSO-containing medium (reduction of 11 6
15%). TPA, however, had no effect (Fig. 8). This suggests that
PKA inhibits the agonist-induced potassium current by phosphor-
ylation of a site downstream of phospholipase activation, e.g., the
potassium channel. In contrast, PKC phosphorylation targets a
site upstream of AA, e.g., the receptors, the G-protein, or the
endogenous phospholipase. This last option cannot be excluded
in view of possible differences between the bee venom PLA2 used
in our experiments and the endogenous phospholipase in LGCs.
To further specify the site of action of PKC, we induced
sustained and irreversible activation of the G-protein by repeated
applications of FMRFa by means of the nonhydrolyzable GTP-
analog GTP-g-S (200 mM) as described above (Fig. 5B). This
procedure results in the development of a sustained outward
current, which only slowly runs down after washout of the agonist
(van Tol-Steye et al., 1997). TPA caused a rapid reduction of this
sustained current, as shown in Figure 9A. Within 4 min of per-
fusion, TPA (50 nM) reduced the sustained current by 56 6 8%
(n 5 5), which was significantly different from the reduction of
33 6 7% under control conditions (perfusion with 4a-PMA or
DMSO; n 5 8; p , 0.05; unpaired t test) (Fig. 9B). These results
and those from Figure 8 imply that PKC must act at a site
downstream of the receptor but upstream of AA and may either
target the active G-protein subunit mediating the response or the
endogenous phospholipase.
DISCUSSION
Three main conclusions can be drawn from the present study.
First, the activation of S-like potassium channels in LGCs by
dopamine, APGWa, and FMRFa involves AA and its metabolism
by lipoxygenases. Thus, convergence of dopamine, FMRFa, and
APGWa onto the potassium conductance resides at or upstream
of AA. Second, AA release is probably mediated by G-protein bg
subunits, which activate the phospholipase. Third, the responses
to the agonists are all affected by PKA and PKC, of which PKC
may target a site upstream of the point of convergence and PKA
downstream of this point. A schematic representation of the most
likely signal transduction pathway used by dopamine, APGWa,
and FMRFa to activate S-like K1 channels is given in Figure 10.
4
cated only by upward error bars. TPA strongly reduces the responses to
the agonists. B, Percentage reduction of the FMRFa response after ;16
min perfusion with 50 nM TPA or with a combination of TPA and the
PKC inhibitor staurosporin (1 mM). Staurosporin strongly reduces the
inhibitory effect of TPA. *p , 0.005; unpaired t test; n 5 3 for both
groups.
Figure 7. Phosphorylation by protein kinase C inhibits the responses to
dopamine, APGWa, and FMRFa. A, Repetitively induced responses to
dopamine, APGWa, and FMRFa as indicated, in the absence and pres-
ence of TPA. Current amplitudes ( I ) are normalized to the current
response at t 5 0 (I0). Arrows indicate the start of bath perfusion with 50
nM TPA (black diamonds; n 5 3–5 for each agonist). Control current
responses (contr, open diamonds; n 5 5–6 for each agonist) were obtained
from experiments performed without change of medium. SEMs are indi-
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Dopamine, APGWa, and FMRFa activate a single type
of K1 channel via lipoxygenase metabolites of
arachidonic acid
Several lines of evidence suggest that activation of the common
K1 conductance in LGCs by dopamine, APGWa, and FMRFa be
accomplished by the release of AA and lipoxygenase metabolites.
First, inhibitors of AA formation block the responses to the three
agonists. Second, the responses are mimicked by application of
AA and PLA2, which generates AA from membrane lipids, and
there is occlusion of the responses to PLA2 and FMRFa. Third,
the responses are blocked by inhibitors of lipoxygenases but not of
cyclooxygenases. Apparently, lipoxygenase metabolites cause, di-
rectly or not, opening of the K1 channel. Because the above
results hold for all three agonists, convergence may occur either
at the level of the G-protein, the phospholipase, or AA.
4-BPB not only inhibits AA formation by PLA2 but also by the
combined action of phospholipase C and diacylglycerol lipase
(Blackwell and Flower, 1983; Piomelli et al., 1987a). Our results
with 4-BPB, therefore, do not specify the type of phospholipase
activated by the three agonists.
The presently described responses are closely related to other
receptor-driven K1 currents that are all activated by FMRFa via
formation of lipoxygenase metabolites, i.e., S and S-like currents
in Aplysia sensory neurons (Piomelli et al., 1987a; Belardetti et al.,
1989; Buttner et al., 1989), in identified neurons of Helisoma
(Bahls et al., 1992), and in the caudodorsal cells of Lymnaea (Kits
et al., 1997). Our data imply that, apart from FMRFa, dopamine
and the neuropeptide APGWa also couple to the AA pathway.
Dopamine-induced activation of PLA2 was shown to occur after
D2 receptor expression in Chinese hamster ovary cells (Vial and
Piomelli, 1995) and is suspected to occur in striatal cells (Schinelli
et al., 1994).
Molluscan S-like currents were recently suggested to derive
from a novel class of voltage-independent K1 channels cloned
from mammals and characterized by the occurrence of four
transmembrane segments and two pore-forming P domains per
subunit (Fink et al., 1998; Patel et al., 1998). Overall, these
channels (notably TREK-1) show a strong similarity to S chan-
nels. They are activated by AA and inhibited by PKA-dependent
phosphorylation when expressed in COS cells. However, they do
not respond to lipoxygenase products of AA. Also, the S-like
current in Lymnaea differs from these channels because it does
not follow Goldman–Hodgkin–Katz rectification at potentials
negative to 290 mV and shows a much stronger block by TEA
Figure 8. Potassium current response induced by PLA2 is inhibited by 8-cpt-cAMP but not by TPA. A, Effect of 10 min perfusion with 0.1 mM
8-cpt-cAMP (n 5 6), 50 nM TPA (n 5 3), and the corresponding controls 0.05% DMSO (n 5 4) and 50 nM 4a-PMA (n 5 3) on the potassium current
response to PLA2 (50 U/ml). Responses after perfusion ( I ) are normalized to responses before perfusion (I0). *p , 0.01, significant difference from
control; unpaired t test. B, Current responses to PLA2 before and after perfusion with 8-cpt-cAMP and before and after perfusion with TPA, as
indicated. Differences in response kinetics are caused by differences in duration of PLA2 application and perfusion rate. 8-cpt-cAMP, TPA, and
corresponding control solutions were applied by Y-tube.
Figure 9. TPA inhibits the potassium current induced by irreversible activation of the G-protein. A, The sustained current (measured as Ihold at 240
mV; see legend of Fig. 5B) as a function of time after perfusion with TPA (50 nM) or with the inactive phorbol ester 4a-PMA (50 nM). Perfusion of
TPA or 4a-PMA (indicated by bars) is started directly after repetitive FMRFa applications. TPA (lef t) causes a rapid decrease of the sustained current
compared with the decrease under control conditions, i.e., with 4a-PMA (right). B, Average reduction of the sustained current after 4 min of perfusion
of TPA (56 6 8%; n 5 5) or control medium with inactive phorbol ester 4a-PMA or DMSO (33 6 7%; n 5 8). *p , 0.05; unpaired t test.
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and Ba21 (Kits et al., 1997; van Tol-Steye et al., 1997). The
limited amount of homology between the novel channels (;30%)
suggests a large potential variability that may account for these
differences.
Effects of bg-interacting peptide suggest a role for the
Gbg subunit
We tested the effect of peptide G, a bg-interacting peptide de-
rived from the bg-binding sequence of bARK1, on the
dopamine-induced response under standard conditions and on
the prolonged dopamine- and FMRFa-induced responses ob-
tained with GTP-g-S in the electrode. In both cases, peptide G
inhibited the K1 current, suggesting that bg subunits are the
active G-protein subunits mediating the signal from receptor to
effector. The controls with GTP-g-S showed that the inhibitory
effect of peptide G is not caused by a reduction of the amount of
functional heterotrimeric G-protein, resulting from competition
of the peptide with Ga for binding bg.
The simplest hypothesis incorporating both the G-protein bg
subunit and AA in the signal transduction pathway is to assume
that, after G-protein dissociation, bg causes activation of a phos-
pholipase. As discussed above, AA might be released from mem-
brane phospholipids by PLA2 or by the combined action of PLC
and diacylglycerol lipases. PLC can be directly activated by bg
subunits, and PLA2 also has been suggested to be activated,
whether or not directly, by bg subunits (Jelsema and Axelrod,
1987; Murayama et al., 1990; Exton, 1997). Alternatively, AA
might activate a G-protein, after which the K1 channels are
directly activated by Gbg. Such a scheme was proposed to explain
AA modulation of GIRKs in atrial cells (Kurachi et al., 1989). It
is, however, very unlikely that this hypothesis explains our results.
The result that TPA inhibited the K1 current induced by GTP-
g-S, but not the PLA2-induced current, suggests that there is no
G-protein acting downstream of PLA2. Moreover, preliminary
experiments failed to show an effect of peptide G on the PLA2-
induced current response (K. Kits and J. C. Lodder, unpublished
observations).
The concentration of peptide G we used to inject was 5 mM. We
estimate that, at maximum, ;1% of the cell volume was injected,
implying that the final concentration of the peptide was always
,50 mM. At this concentration, the K1 currents were inhibited by
50% or more. A similar IC50 value (76 mM) was reported for
inhibition of bg-stimulated bARK1 activity by peptide G in rod
outer segment membranes (Koch et al., 1993), suggesting that the
affinity of bg for the peptide is similar in both cases, despite
possible differences between molluscan and mammalian bg. A
much lower IC50 value (65 nM), however, was found for inhibition
by peptide G of angiotensin II-mediated stimulation of L-type
calcium channels in rat myocytes (Marcez et al., 1997).
All responses are modulated by phosphorylation at
two different sites in the AA pathway
All three responses are inhibited by (analogs of) cAMP and by
PKC-activating phorbol ester. These effects were relieved in the
presence of PKA and PKC inhibitors, respectively, indicating that
phosphorylation by PKA and PKC mediates the inhibition. More-
over, the dopamine response was reduced by the phosphatase
inhibitor okadaic acid. Apparently, phosphorylation counteracts
the signaling induced by dopamine, APGWa, and FMRFa.
The observation that 8-cpt-cAMP also inhibited the outward
current induced by exogenous PLA2 suggests that PKA-
dependent phosphorylation occurs at a site downstream of AA
release, e.g., the channel. It cannot be excluded that inhibition of
PKA by lipoxygenase metabolites of AA (or possibly activation of
a phosphatase) is the actual trigger for opening of the K1 chan-
nel. However, if dopamine would inhibit PKA activity, it does not
achieve this via inhibition of adenylyl cyclase, because dopamine
does not inhibit adenylyl-cyclase in LGCs (Werkman et al., 1990).
An alternative and more simple explanation is that PKA-
dependent phosphorylation forms a modulatory pathway. Either
Figure 10. Minimal hypothetical
scheme of the signal transduction
routes involved in regulation of the
receptor-driven K 1 channels. Boxes
indicate that different isoforms may be
used. Dashed arrows indicate equally
probable options. PL, Phospholipase;
LO, lipoxygenase.
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way, the fact that not only cAMP but also okadaic acid affects the
responses suggests that a basal level of phosphorylation controls
the activity of the K1 channels. The presumed mammalian S-like
channel, TREK-1, has a PKA consensus site in its cytoplasmic
C-terminal region, which is critical for 8-cpt-cAMP mediated
downmodulation of the channel (Patel et al., 1998).
Interestingly, a similar relationship as found here between
AA-dependent activation of K1 channels and (de)phosphoryla-
tion has been reported in sensory neurons of Aplysia. The S
channels in these cells are activated by FMRFa via 12-
lipoxygenase metabolites of AA, and they are inhibited by sero-
tonin via PKA-dependent phosphorylation of the channel or an
associated protein (Shuster et al., 1985; Belardetti and
Siegelbaum, 1988). In addition to the AA metabolite-dependent
effect on the S channel, which is thought to be independent of
(de)phosphorylation (Belardetti et al., 1989; Buttner et al., 1989),
FMRFa also reverses PKA-dependent phosphorylation in the
sensory neurons (Belardetti and Siegelbaum, 1988; Sweatt et al.,
1989; Shi and Belardetti, 1991). There are indications that de-
phosphorylation is secondary to AA formation and not depen-
dent on inhibition of adenylyl-cyclase or stimulation of phospho-
diesterase activity (Volterra and Siegelbaum, 1988; Sweatt et al.,
1989; Shi and Belardetti, 1991). A similar mechanism might be
active in the LGCs.
Although both PKA and PKC suppress the responses to dopa-
mine, APGWa, and FMRFa, there is a clear differential effect of
the two kinases. Unlike 8-cpt-cAMP, the phorbol ester TPA
failed to inhibit PLA2-induced K
1 currents. TPA, however, in-
hibited the GTP-g-S-activated sustained current. Therefore, PKC
most likely targets a site upstream of AA, presumably the Gbg
subunit or the phospholipase. Interestingly, Lymnaea G-protein b
subunits contain six consensus sites for PKC phosphorylation (Knol
et al., 1994; H. van Heerikhuizen, unpublished observations).
Thus, the responses to all three agonists are affected by PKA
and PKC, of which PKC may act at a site upstream of the putative
point of convergence (AA) and PKA downstream of AA. This
suggests a modulatory role for receptors that stimulate PKA- or
PKC-activity in LGCs. Candidate agonists for such receptors are
acetylcholine and conopressin that induce depolarizations in
LGCs, an effect that is also produced by injections of cAMP
(Stoof et al., 1984). The ability of conopressin to activate PKC in
Lymnaea anterior lobe neurons was recently demonstrated in our
lab (P. F. van Soest, unpublished observations).
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